TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 335 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $86,323,000 | -58.0% | 4,727,415 | -58.1% | 1.98% | -62.9% |
| Q4 2020 | $205,584,000 | +2.0% | 11,295,846 | 0.0% | 5.34% | -15.0% |
| Q3 2020 | $201,518,000 | -2.2% | 11,295,846 | -1.7% | 6.28% | -4.6% |
| Q2 2020 | $205,960,000 | +2.4% | 11,486,905 | -13.3% | 6.58% | -14.2% |
| Q1 2020 | $201,055,000 | -23.1% | 13,244,711 | 0.0% | 7.67% | +36.0% |
| Q4 2019 | $261,318,000 | +14.7% | 13,244,711 | 0.0% | 5.64% | +23.7% |
| Q3 2019 | $227,809,000 | -2.8% | 13,244,711 | 0.0% | 4.56% | +14.5% |
| Q2 2019 | $234,431,000 | -56.6% | 13,244,711 | -50.0% | 3.98% | -30.9% |
| Q1 2019 | $539,590,000 | – | 26,489,422 | – | 5.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |